Table 2 Laboratory findings.

From: Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation

 

Control (n = 60)

No MHE (n = 46)

MHE (n = 48)

CHE (n = 27)

GLU (mmol/L)

7.0 ± 3.6

6.3 ± 3.5

7.1 ± 5.5

7.8 ± 6.9

WBC (109/L)

8.3 ± 4.1

9.2 ± 3.7

9.1 ± 4.2

8.8 ± 3.8

Neutrophils (%)

59.5 ± 20.2

58.5 ± 21.6

62.2 ± 28.1

64.2 ± 22.6

Lymphocytes (%)

38.1 ± 15.5

37.2 ± 22.8

36.5 ± 19.8

39.9 ± 24.2

HB (g/dL)

120.1 ± 29.2

129.1 ± 33.2

117.4 ± 34.6

107.7 ± 25.7

PLT (10/L)

310.2 ± 113.5

288.1 ± 112.0

299.2 ± 161.1

273.8 ± 133.2

ALT (IU/L)

33.2 ± 6.5

65.1 ± 34.3

79.8 ± 53.7

123.3 ± 66.2

AST (IU/L)

26.7 ± 7.4

74.8 ± 48.7

87.4 ± 58.6

132.6 ± 71.7

CK-MB (IU/L)

19.2 ± 24.1

22.5 ± 29.4

27.1 ± 30.7

24.2 ± 23.6

CRP (mg/L)

4.3 ± 3.8

3.8 ± 3.5

4.6 ± 4.1

5.7 ± 4.6

LDH (U/L)

218.2 ± 75.1

241.4 ± 81.2

234.1 ± 65.8

242.5 ± 75.5

K (mmol/L)

4.1 ± 1.9

4.5 ± 1.4

4.7 ± 1.3

4.9 ± 1.7

Na (mmol/L)

130.6 ± 3.62

141.3 ± 5.5

133.3 ± 5.3

135.9 ± 7.6

CL (mmol/L)

100.5 ± 30.7

106.3 ± 45.2

115.9 ± 37.7

116.9 ± 41.6

Prothrombin time (s)

12.3 ± 3.0

18.8 ± 5.8

19.4 ± 6.3

19.1 ± 7.0

Bilirubin (mg/dL)

0.8 ± 0.6

2.8 ± 1.2

2.3 ± 0.8

2.7 ± 1.6

Ammonia (uM)

66.5 ± 34.3

161.2 ± 68.4

175.3 ± 54.6

178.8 ± 71.2

  1. MHE: minimal hepatic encephalopathy, CHE: clinical hepatic encephalopathy, GLU: blood glucose, LYM: percentage of lymphocytes, ALT: alanine aminotransferase, CL: blood chlorine, WBC: white blood cell counts, CK: creatine kinase, CK-MB: creatine kinase-MB, CRP: C-reactive protein, LDH: Lactate dehydrogenase
Back to article page